immunity News and Research

RSS

Impact of engineered ACE2-Fc on SARS-CoV-2 infection

Researchers employ a structure-guided approach for the development of a series of ACE2-Fc variants using human IgG1 or IgG3 backbone.

1 Dec 2021

Novel approach to estimate transmission advantage of SARS-CoV-2 variants in real-time

A new study retrospectively estimates the effective transmission advantage of the Alpha variant as compared to other non-VOC lineages.

1 Dec 2021

Longer interval between COVID-19 mRNA vaccine doses leads to stronger immune response

The first peer-reviewed study in North America examining the timing between the first and second doses of COVID-19 mRNA vaccines shows that a longer dose interval leads to a stronger immune response. The study is funded by the Government of Canada through its COVID-19 Immunity Task Force.

1 Dec 2021

Impact of partial lockdown on breaking COVID-19 fourth wave in Bavaria

An agent-based simulator was used to determine the historical course of COVID-19 and to analyze the effectiveness of lockdown.

1 Dec 2021

Safety and immunogenicity of different COVID-19 booster vaccines

New study findings suggest that booster vaccination with an mRNA-based vaccine has the highest immunogenicity against the COVID-19 Delta variant.

1 Dec 2021

Interventions for preventing COVID-19 outbreaks in military basic training

New research findings suggest that military basic training is a unique environment that necessitates the development of tailored solutions for minimizing COVID-19 outbreaks.

1 Dec 2021

Grouping of immunological T-cell receptors may be key to identifying patients' history of infection

Grouping of pathogen-recognizing proteins on immune T cells may be key to identifying if someone has had an infection in the past, suggests a study published today in eLife.

1 Dec 2021

Impact of SARS-CoV-2 on oral health

New research examined SARS-CoV-2 and its impact on oral health and suggests that survival against the infection may be partially dependent on such factors.

1 Dec 2021

Role of interferon type I-driven responses associated with disease control in COVID-19

New research suggests that treatment with type I interferons in the early stage of COVID-19 may supress disease progression by limiting SARS-CoV-2 in hosts.

1 Dec 2021

Novel anti-inflammatory drug target identified by CRISPR

In this interview, News-Medical speaks to Dr. Jeffrey Rathmell about his recent research into how metabolic pathways impact immune function.

1 Dec 2021

Study identifies two genes that play key role in protecting ovarian cancer from the immune system

Immunotherapies have shown striking clinical benefit in the treatment of many cancers, especially when used in combination with chemotherapy.

30 Nov 2021

Longer between-dose intervals for COVID-19 vaccines may significantly reduce mortality

A recent study, currently available on the medRxiv* preprint server, has shown how longer dosing intervals of vaccines against coronavirus disease (COVID-19) may be able to minimize mortality in low- and middle-income countries in the WHO European region – and significantly change our vaccination strategy.

30 Nov 2021

Review highlights oncolytic viruses with remarkable ability to destroy cancer cells

With the world still in the grip of a devastating pandemic, it's hard to imagine viruses as something other than hostile enemies to be vanquished.

30 Nov 2021

Natural COVID-19 infection offers protection from gamma and delta variants of SARS-CoV-2

Natural infection with COVID-19 offered protection from reinfection when the gamma and delta variants predominated, according to a new University of Michigan study that also provides levels of antibodies needed to protect against reinfections.

30 Nov 2021

Northwestern researchers continue to tackle every facet of COVID-19 pandemic

As the COVID-19 pandemic nears the two-year mark, Northwestern Medicine scientists continue to tackle every facet of the disease, from investigating coronavirus vaccines' potential for providing immunity against similar coronaviruses to developing novel rapid antigen-based tests and examining disparities in COVID-19 case and mortality rates in Chicago.

30 Nov 2021

Johannes Gutenberg University Mainz participates in new Collaborative Research Center

The German Research Foundation has approved the establishment of a new Collaborative Research Center in the field of materials science, in which Johannes Gutenberg University Mainz is participating with a pioneering subproject. In addition, an existing CRC coordinated by JGU was approved for a further funding period of four years.

30 Nov 2021

immunity News and Research

Impact of engineered ACE2-Fc on SARS-CoV-2 infection

Novel approach to estimate transmission advantage of SARS-CoV-2 variants in real-time

Longer interval between COVID-19 mRNA vaccine doses leads to stronger immune response

Impact of partial lockdown on breaking COVID-19 fourth wave in Bavaria

Safety and immunogenicity of different COVID-19 booster vaccines

Interventions for preventing COVID-19 outbreaks in military basic training

Grouping of immunological T-cell receptors may be key to identifying patients' history of infection

Impact of SARS-CoV-2 on oral health

Role of interferon type I-driven responses associated with disease control in COVID-19

Novel anti-inflammatory drug target identified by CRISPR

Study identifies two genes that play key role in protecting ovarian cancer from the immune system

Longer between-dose intervals for COVID-19 vaccines may significantly reduce mortality

Review highlights oncolytic viruses with remarkable ability to destroy cancer cells

Natural COVID-19 infection offers protection from gamma and delta variants of SARS-CoV-2

Northwestern researchers continue to tackle every facet of COVID-19 pandemic

Johannes Gutenberg University Mainz participates in new Collaborative Research Center

COVID-19 booster jabs to be offered to all adults in England by the end of January

Omicron and other coronavirus variants: What you need to know

Host and in vitro genomic variability of SARS-CoV-2 and its variants

UK study finds COVID-19 from Delta and Alpha infections are clinically similar

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News